Kovitz Investment Group Partners LLC Has $362,000 Position in Takeda Pharmaceutical Company Limited (NYSE:TAK)

Kovitz Investment Group Partners LLC lifted its stake in Takeda Pharmaceutical Company Limited (NYSE:TAK) by 7.0% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 25,456 shares of the company’s stock after purchasing an additional 1,670 shares during the period. Kovitz Investment Group Partners LLC’s holdings in Takeda Pharmaceutical were worth $362,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also modified their holdings of the stock. Catalytic Wealth RIA LLC increased its holdings in shares of Takeda Pharmaceutical by 4.0% in the second quarter. Catalytic Wealth RIA LLC now owns 21,703 shares of the company’s stock valued at $281,000 after purchasing an additional 841 shares in the last quarter. EverSource Wealth Advisors LLC grew its holdings in Takeda Pharmaceutical by 38.6% during the 2nd quarter. EverSource Wealth Advisors LLC now owns 3,082 shares of the company’s stock worth $43,000 after acquiring an additional 859 shares during the period. Hexagon Capital Partners LLC grew its holdings in Takeda Pharmaceutical by 34.3% during the 3rd quarter. Hexagon Capital Partners LLC now owns 4,419 shares of the company’s stock worth $63,000 after acquiring an additional 1,129 shares during the period. Gallacher Capital Management LLC grew its holdings in Takeda Pharmaceutical by 7.0% during the 2nd quarter. Gallacher Capital Management LLC now owns 17,365 shares of the company’s stock worth $225,000 after acquiring an additional 1,136 shares during the period. Finally, Cutter & CO Brokerage Inc. grew its holdings in Takeda Pharmaceutical by 3.3% during the 2nd quarter. Cutter & CO Brokerage Inc. now owns 41,974 shares of the company’s stock worth $543,000 after acquiring an additional 1,347 shares during the period. Institutional investors and hedge funds own 9.17% of the company’s stock.

Takeda Pharmaceutical Price Performance

TAK opened at $13.42 on Friday. The company has a fifty day moving average price of $13.81 and a two-hundred day moving average price of $13.87. The company has a debt-to-equity ratio of 0.64, a quick ratio of 0.77 and a current ratio of 1.28. Takeda Pharmaceutical Company Limited has a 52 week low of $12.57 and a 52 week high of $15.08. The firm has a market capitalization of $42.70 billion, a PE ratio of 23.14, a P/E/G ratio of 0.26 and a beta of 0.51.

Takeda Pharmaceutical Company Profile

Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived therapies, immunology, oncology, and neuroscience.